-
Rail journey offers a slower route to a Berlin city break
-
Energy bill plan could use HMRC income data to target support
-
Arsenal control title race as Manchester United fall into bottom three
-
Business owner earning £6,000 a month tackles £70,000 debt
-
Suspected Krakow gunman dies after attack that killed six
-
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
-
Carrick backs Dalot after hostile reception from Manchester United fans
-
Comet returns as online electrical marketplace 14 years after collapse
-
Aston Villa Defy History With Rare Victory at Old Trafford
-
Brussels Education Unions Schedule Major November Protest Over Funding and Reforms
-
Crowds Gather at San Francisco Park for Elizabeth Holmes Lookalike Tournament
-
Hancock Health Expands Robot Specimen Delivery to Parkway Building, Adding Scheduled and On-Demand Runs to the Lab
-
Releaf Unveils UK-first THCV for Weight Management
-
Gabriel Provides Corporate Update
-
AsiaFIN's Insite MY Holdings and MENA Insite MY Sign Distributorship Agreement and Announce Second Bank Customer in Saudi Arabia
-
Ai4 Celebrates Successful Debut of Applied AI Research Conference (AAIRC), Bridging Academic Research and Industry Innovation
-
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
-
Nextech3D.ai Closes $720,000 Management-Led Private Placement
-
CoTec Holdings Corp. Notes HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Silver Storm Reports Concentrate Deliveries from La Parrilla
-
Ispire Technology Inc. Reports First Quarter Fiscal Year 2027 Financial Results
-
HyProMag USA Advances North Texas Rare Earth Magnet Facility With First Major Equipment Delivery
-
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
-
Tintina Mines Intersects 460m at 0.50% CuEq at the Dos Amigos Copper-Gold Project in Chile
-
Pace Launches Three-Business-Day Culture-Based 'L. pneumophila' Testing
-
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
-
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 09
-
Making Your Home Safer for Aging Parents: Accessibility Renovations That Add Value
-
New 401k Gold IRA Investment Guide Explains the Best Way to Invest in Gold for Retirement (2026 Update)
-
United States Antimony Corporation Announces Webcast Time set for Thursday, November 12, 2026 at 4:15 PM ET to Report on Third Quarter and Nine Months Ended September 30, 2026 Financial and Operating Results
-
Pacific Edge Labs Publishes More Than 120 Independent Lab Reports, Each Listed With the Testing Lab's Own ID
-
Regentis Signs Exclusive Distribution Agreement with AMI Technologies to Commercialize GelrinC(R) in Israel
-
Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery
-
Shelfietech Launched New Retail Software Platform
-
A Holiday-Season Moment for Penny-Stock Followers and Microcap Visionaries as Elektros Moves Its EV Patent Forward
-
Dolphin Subsidiary 42West Drives Global Communications Behind Box Office Leaders Godzilla Minus Zero and Ramayana
-
Visterra Landscape Group Expands Into Arkansas With Strategic Investment In Little Rock Landscape
-
Santa Claus Has Come Early: Elektros Brings An Early-Christmas Spark To Its Patented EV Charging Vision
-
SMX Is Building a Verifiable Identity Layer for Fashion, From Cotton Fields to Luxury Resale
-
Gladstone Land Corporation Earnings Call and Webcast Information
-
The Metals Royalty Company to Host Corporate Update Webinar on November 16, 2026
-
Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors
-
Eylsia Nicolas Launches Global "Wake Me Up" Franchise After Surpassing 100 Million Meta Views in One Week
-
BioLargo Targets Growing Industrial PFAS Market with MasterClass at International Water Conference
-
Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
-
IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
-
iPS Cell Research Accelerates Drug Discovery for ALS and Spinal Cord Injury
-
Central Tokyo Apartment Rents Forecast to Rise 11% by 2030
US Navy veterans battle PTSD with psychedelics
Suicide is a tragic epidemic among US military veterans, but a new documentary charts how psychedelic drugs offer a glimmer of hope to elite soldiers battling post-traumatic stress disorder and depression.
"We're not scientists, we don't know exactly what's happening," said Jon Shenk, who co-directed "In Waves and War" with his wife Bonni Cohen.
"But it does seem like there's something to it," he told AFP.
Streaming on Netflix from Monday, the documentary follows three retired US Navy SEALs coping with the invisible scars of their many tours of Iraq and Afghanistan.
After years spent under enemy fire, the veterans have become trapped on an altogether different battlefield, contending with PTSD, brain injuries, depression and alcoholism.
They have been prescribed cocktails of antidepressants, which not only fail to help, but leave them unrecognizable to their loved ones, and bring their families to "a breaking point in their treatment of their own trauma," says Cohen.
The trio head to Mexico for an experimental treatment, which offers an unexpected lifeline via two psychedelic drugs: ibogaine, extracted from an African shrub, and 5-MeO-DMT, derived from the secretions of the Colorado River toad.
- 'Reboot' -
"It's like a complete reboot," Marcus Capone, a former soldier and subject of the film, told AFP.
"It kind of brings you back to your truer self, before you had any real struggles or real issues in your life."
According to his wife Amber, the treatment "is bringing hope to the hopeless."
With their organization Veterans Exploring Treatment Solutions, the couple have taken some 1,200 US veterans to Mexico for treatment since 2019.
Once there, they can receive substances that are illegal in the United States and most other countries.
By gaining the Capones' trust, the documentary makers were able to infiltrate and spotlight a community where secrecy and moral rectitude are musts.
At first, many patients are skeptical about substances historically associated with the excesses of the American sub-culture.
Among them is veteran Matty Roberts, another of the film's subjects.
"If this crazy hippie-ass shit helps, if it helped my friends, then maybe I should do it," he says with a sigh in one scene from the film.
His transformation is all the more dramatic. The documentary shows Roberts groaning with nausea and breaking down in tears from the drugs, before emerging with a new perspective on life.
These intimate moments are accompanied with animated sequences, illustrating the veterans' inner journeys through the dark corners of their unconscious and their deepest wounds.
- 'Expand' -
In recent years, the therapeutic potential of psychedelic substances like psilocybin -- the active ingredient of magic mushrooms -- as well as LSD and MDMA has sparked renewed interest among scientists for treating depression and addiction.
The documentary shows Stanford University researchers intrigued by the veterans' sudden mental improvement after treatment. But it does not delve into how exactly these drugs rewire the brain, or their potential dangers -- ibogaine, for example, can damage the heart.
"We wanted to make an emotional film that drew you in," said Cohen.
"Also the studies are really exciting, but they're just at the beginnings."
For their part, the veterans hope their stories can convince US politicians to change regulations that currently impede the study of these drugs.
"We need all these medicines to be researched more," said Marcus Capone.
His wife Amber said they are not calling for these drugs to be legalized.
"What we're saying is, let's expand the data. Let's reduce the barriers to research so that we can grow the data set and better understand if these therapies are viable," she said.
It is a plea that resonates across party lines in the United States.
Democratic-led Oregon and Colorado have recently allowed the supervised use of psilocybin. And this summer, Republican-controlled Texas passed a law to invest $50 million of public funds for research into ibogaine.
According to the most current data available from the US Department of Veterans Affairs, there were 6,407 veteran suicides in 2022 -- more than 17 a day.
If you are a US veteran in need of help, or concerned about one, you can dial 988 and press 1, or visit www.veteranscrisisline.net.
D.Sawyer--AMWN